Costs associated with adverse events for systemic therapies in metastatic melanoma.
CONCLUSION: The costs of AEs associated with systemic therapies for MM are substantial.
PMID: 30192155 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Gastroenterology | General Medicine | Heart | Hematology | Melanoma | Nutrition | Psychiatry | Respiratory Medicine | Skin Cancer | Study